| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.077 | 17.807 | 37.723 | 61.541 | 37.845 | 42.104 | 41.551 | 32.003 | 13.012 |
| Total Income - EUR | - | 8.077 | 17.807 | 37.723 | 61.541 | 37.845 | 42.104 | 41.551 | 32.003 | 13.012 |
| Total Expenses - EUR | - | 3.317 | 12.832 | 13.865 | 26.684 | 8.988 | 6.784 | 17.449 | 13.352 | 10.169 |
| Gross Profit/Loss - EUR | - | 4.761 | 4.976 | 23.858 | 34.857 | 28.857 | 35.321 | 24.102 | 18.650 | 2.843 |
| Net Profit/Loss - EUR | - | 4.518 | 4.441 | 22.727 | 33.011 | 27.810 | 34.083 | 22.880 | 18.340 | 2.096 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Realscan Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 99 | 2.758 | 1.502 | 704 | 1.589 | 547 | 3.236 | 3.226 | 3.208 |
| Current Assets | - | 5.251 | 6.930 | 22.575 | 44.901 | 70.584 | 65.386 | 20.007 | 15.360 | 2.850 |
| Inventories | - | 0 | 0 | 2.262 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 346 | 0 | 4.047 | 3.591 | 2.671 | 1.885 | 1.150 | 14.823 | 487 |
| Cash | - | 4.904 | 6.930 | 16.266 | 41.310 | 67.913 | 63.501 | 18.857 | 537 | 2.363 |
| Shareholders Funds | - | 4.563 | 8.927 | 22.778 | 44.917 | 71.876 | 65.148 | 22.929 | 18.388 | 6.022 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 786 | 760 | 1.299 | 688 | 297 | 785 | 314 | 198 | 37 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Realscan Medical Srl